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Introduction 
Lymphatic filariasis, caused by Brugia 
malayi and Brugia timori, is endemic in 
several Asian countries and infects ~ 13 
million people.  The WHO initiated Global 
Program for Elimination of Lymphatic 
Filariasis (GPELF) aims to eliminate the 
disease as a public health problem by the year 
2020.  To ensure its success, a sensitive and 
specific field applicable diagnostic tool is 
needed for mapping and monitoring all phases 
of the program. For bancroftian filariasis 
caused by Wuchereria bancrofti, the ICT 
antigen card test is widely used for this 
purpose. This test is based on the detection of 
a circulating adult worm antigen of W. 
bancrofti (Chandrashekar et al., 1999). 
Detection of anti-filarial IgG4 antibody 
provides a good alternative diagnostic tool for 
brugian filariasis as this antibody subclass has 
been shown to be elevated in active infection 
and declines post-treatment (Haarbrink et al., 
1999). Recombinant antigen-based antibody 
assays would be preferable over assays based 
on parasite extracts since the former allow for 
unlimited supply of well-defined antigens.  
The BmR1 recombinant antigen, expressed 
by gene pPROEX/ Bm17DIII (GenBank 
accession no. AF225296) has been shown by 
us to be a highly specific and sensitive antigen 
for IgG4 assays to detect exposure to both B. 
malayi and B. timori infections. The antigen 
was used in ELISA and rapid test (Brugia 
Rapid) formats and evaluation in various 
laboratories and field trials revealed a 
sensitivity of 93%-100% in detecting mf 
positive individuals (Supali et al., 2004; 
Rahmah et al., 2003b).  
The BmR1 antigen was very specific (99% 
-100%) with respect to reactivity with sera 
from non-filarial infections (Rahmah et al., 
2003b). The highest prevalence of cross-
reacting antibodies in other filarial infections 
was found in W. bancrofti, followed by  Loa 
loa; while only one sample (of 9) patients  
with Dirofilaria infection. However cross-
reactivity was not found in patients with 
Onchocerca volvulus or Mansonella infection 
(Fischer et al., in press, Rahmah et al., 
2003b). 
Due to its diagnostic significance, it is 
therefore important to characterize the BmR1 
antigen more closely. The varying degree of 
BmR1 recognition in other filarial infection 
raises the question whether the homologous 
antigen is also present in W. bancrofti, L. loa 
and O. volvulus.  
 
Materials and methods 
 
cDNA and genomic DNA 
W. bancrofti microfilaria (mf), adult male 
and adult female cDNA libraries were 
obtained from Filarial Genome Project 
Resource Centre (Smith College, 
Northampton, USA). Genomic DNA of W. 
bancrofti was prepared from mf provided by 
the author from ICMR; comprised two 
negative samples and two positive samples by 
Brugia Rapid test. L. loa L3 and O. volvulus 
mf cDNA libraries were kindly provided by 
Dr. Peter Fischer from Germany. 
 
PCR  
PCR primers used to amplify the entire 
Bm17DIII gene sequence, were RNF (24 mer) 
5’att act gat tag tat ttt atc gtt 3’ and RNR (24 
mer) 5’atg ata aaa atg aat gag aaa tat 3’. λ 
phage plaques were amplified and the DNA 
was extracted using λ DNA extraction kit 
(Qiagen, Germany). PCR was then performed 
in a thermocycler (Perkin Elmer, USA) at: 
94ºC, 5mins; 55ºC, 5mins; 35 cycles for 94ºC, 
45sec; 55ºC, 45sec & 72ºC, 90sec; 72ºC, 
10mins. W. bancrofti mf genomic DNA from 
was prepared using Genispin Tissue DNA Kit 
(BioSynTech, Malaysia) and amplifications 
was performed at: 94ºC, 5mins; 35 cycles for 
94ºC, 1min; 55ºC, 1min & 72ºC, 1min; 72ºC, 
10mins. 
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TOPO cloning and DNA sequence analysis 
PCR products of the homologs gene were 
cloned into TOPO-TA vector (Invitrogen, 
USA), and then transformed into E. coli 
TOP10 host (Invitrogen). The recombinant 
plasmids were amplified, purified using 
QIAprep® Spin Miniprep Kit (Qiagen, 
Germany), and sequenced (ACGT Inc, USA) 
before analyzed using vector NTI software. 
 
Subcloning, expression and purification of 
Ov17DIII/Loa17DIII 
The Bm17DIII gene homolog in O. 
volvulus/L. loa were subcloned into a bacterial 
expression vector, pPROEX-HT which 
contain 6-His tag (Life Technologies, USA), 
and then transformed into E. coli TOP 10 host 
cells.   
The recombinant bacteria were cultured in 
Terrific broth and placed in a 37°C shaker 
incubator until the OD600 reached 0.5. The 
culture then induced with 1 mM IPTG for 3 
hrs at 30°C. The bacterial pellet was 
reconstituted with lysis buffer containing 50 
mM Tris HCl (pH 8.5), 5 mM 2-
mercaptoethanol and a cocktail of protease 
inhibitors (Roche Diagnostics, Germany). The 
suspension was sonicated, followed by 
centrifugation at 12000xg, 30 minutes; and the 
resulting supernatant purified using Ni-NTA 




The methodology employed was as 
previously reported (Rahmah et al., 2001a). 
Briefly, microtiter wells (Nunc, USA) were 
coated with 100 µl either with BmR1 (20 
µg/ml) or Ov-BmR1/Loa-BmR1 recombinant 
antigens (5, 10 or 20 µg/ml) in NaHCO3 
buffer (pH 9.6). After a blocking step, serum 
samples (1:20 or 1:50 or 1:100) were 
incubated for 2h, followed by 0.5 h incubation 
with the secondary antibody HRP conjugated 
to monoclonal anti-human IgG1 (1:6000), 
IgG2 (1:1000, 1:2000), IgG3 (1:1000, 1:2000) 
or IgG4 (1:4500) (CLB, Netherlands). 
Subsequently, ABTS substrate (Roche 
Diagnostics) was added for 30 minutes before 
the optical densities (OD) were read at 410 nm 
with an ELISA spectrophotometer (Dynatech, 
USA).  
A panel of 262 sera samples was from pre-
existing serum banks. The O. volvulus sera 
were from mf positive individuals from 
Western Uganda. L. loa sera were from mf 
positive individuals from the clinical 
department of BNI. W. bancrofti sera were 
from India; while sera from B. malayi 
infections, endemic normals (both disease and 
Brugia Rapid negative), non-endemic normals 
(healthy blood donors) and other parasitic 
infections were from Malaysia. Infections 
with other parasites comprised patients from 
Malaysia whose stool specimens were positive 
for parasite ova/larva (single or mixed 
infections with Ascaris lumbricoides, 
Trichuris trichiura, hookworm, Strongyloides 
stercoralis); patients with clinical presentation 
and serology consistent with toxocariasis and 
amoebiasis; and a patient with Gnathostoma 




Identification of the BmR1 homolog 
PCR of W. bancrofti cDNA libraries and 
W. bancrofti genomic DNA (from all 4 mf 
samples) produced a single band of 618 bp. A 
total of 12 recombinant clones, from six 
TOPO reactions (2 from mf cDNA, 1 from 
adult female cDNA, 1 from adult male cDNA 
and 2 from mf genomic DNA) were 
sequenced. A total of 31 DNA sequencing 
reactions were analyzed and all obtained 
sequences were identical. Comparison of the 
obtained nucleotide sequence showed that it is 
100% identical to the cDNA sequence of 
BmR1, irrespective whether the template DNA 
came from cDNA libraries, or mf originated 
from individuals positive or negative for 
Brugia Rapid test.    
For identification of the cDNA of the 
BmR1 homolog in O. volvulus and L. loa, a 
total of 5 and 3 recombinant clones were 
sequenced respectively (comprising a total of 
20 reactions). The O. volvulus and the L. loa 
homolog were 100% identical to each other; 
and only two bases were different from the B. 
malayi and W. bancrofti homolog, i.e at 97bp 
and 483bp, and only one amino acid 
difference observed. The uncharged, polar 
isoleucine at position 33 was substituted by a 
neutral threonine. (Figure 1)  
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  (a)          1                                                 50 
» Ov/Loa17DIII    (1)  ATGATAAAAATGAATGAGAAATATGTTAAAGAATTGATACTACTGCTGTT 
    » Bm17DIII    (1)  ATGATAAAAATGAATGAGAAATATGTTAAAGAATTGATACTACTGCTGTT 
      Contig 1    (1)  ATGATAAAAATGAATGAGAAATATGTTAAAGAATTGATACTACTGCTGTT 
                      51                                                100 
» Ov/Loa17DIII   (50)  GTTCGCTATGATATATACATCGTTAGAGTCGAATTGTGAATTTTGGACCG 
    » Bm17DIII   (50)  GTTCGCTATGATATATACATCGTTAGAGTCGAATTGTGAATTTTGGATCG 
      Contig 1   (50)  GTTCGCTATGATATATACATCGTTAGAGTCGAATTGTGAATTTTGGAYCG 
                     101                                                150 
» Ov/Loa17DIII  (100)  AAGATGATTTTCATCCATTTGTGCCAAAATCAGAGGAAGCACGAGAAGAA 
    » Bm17DIII  (100)  AAGATGATTTTCATCCATTTGTGCCAAAATCAGAGGAAGCACGAGAAGAA 
      Contig 1  (100)  AAGATGATTTTCATCCATTTGTGCCAAAATCAGAGGAAGCACGAGAAGAA 
                     151                                                200 
» Ov/Loa17DIII  (150)  TATTGCGGTTTCTTTAAAGAAATGAATTTGTCCAGAAATGAGTTAATGGA 
    » Bm17DIII  (150)  TATTGCGGTTTCTTTAAAGAAATGAATTTGTCCAGAAATGAGTTAATGGA 
      Contig 1  (150)  TATTGCGGTTTCTTTAAAGAAATGAATTTGTCCAGAAATGAGTTAATGGA 
                     201                                                250 
» Ov/Loa17DIII  (200)  TACAATCAGGAAATGGGCATCAAAATATGGAGTTTTGGAACAATTTGATA 
    » Bm17DIII  (200)  TACAATCAGGAAATGGGCATCAAAATATGGAGTTTTGGAACAATTTGATA 
      Contig 1  (200)  TACAATCAGGAAATGGGCATCAAAATATGGAGTTTTGGAACAATTTGATA 
                     251                                                300 
» Ov/Loa17DIII  (250)  ACTACGTTGACGAAGAGTTACGATACGAAAATATGGTTTATGATATATTC 
    » Bm17DIII  (250)  ACTACGTTGACGAAGAGTTACGATACGAAAATATGGTTTATGATATATTC 
      Contig 1  (250)  ACTACGTTGACGAAGAGTTACGATACGAAAATATGGTTTATGATATATTC 
                     301                                                350 
» Ov/Loa17DIII  (300)  AAGGATAAAGTTAACAGTACATGTGGGAGTGAAAAAATTAAGAGAACTCT 
    » Bm17DIII  (300)  AAGGATAAAGTTAACAGTACATGTGGGAGTGAAAAAATTAAGAGAACTCT 
      Contig 1  (300)  AAGGATAAAGTTAACAGTACATGTGGGAGTGAAAAAATTAAGAGAACTCT 
                     351                                                400 
» Ov/Loa17DIII  (350)  TTTCGAAATAACAGATTTGCTAACAGACAGAGATACTGCACAACAAACGA 
    » Bm17DIII  (350)  TTTCGAAATAACAGATTTGCTAACAGACAGAGATACTGCACAACAAACGA 
      Contig 1  (350)  TTTCGAAATAACAGATTTGCTAACAGACAGAGATACTGCACAACAAACGA 
                     401                                                450 
» Ov/Loa17DIII  (400)  TTCAGACTAAAATTGATGAAATCATAAATAATTTAAACGAGAGAGAACGG 
    » Bm17DIII  (400)  TTCAGACTAAAATTGATGAAATCATAAATAATTTAAACGAGAGAGAACGG 
      Contig 1  (400)  TTCAGACTAAAATTGATGAAATCATAAATAATTTAAACGAGAGAGAACGG 
                     451                                                500 
» Ov/Loa17DIII  (450)  ATGGAATTAACTCAATTATGGGCGATACTAGGCGAAGAAGCGATCATCGA 
    » Bm17DIII  (450)  ATGGAATTAACTCAATTATGGGCGATACTAGGTGAAGAAGCGATCATCGA 
      Contig 1  (450)  ATGGAATTAACTCAATTATGGGCGATACTAGGYGAAGAAGCGATCATCGA 
                     501                                                550 
» Ov/Loa17DIII  (500)  AGCGCAAGACAAATTTGAAAATGGAAATAGTATTTGGGAAGCAGTTGAAA 
    » Bm17DIII  (500)  AGCGCAAGACAAATTTGAAAATGGAAATAGTATTTGGGAAGCAGTTGAAA 
      Contig 1  (500)  AGCGCAAGACAAATTTGAAAATGGAAATAGTATTTGGGAAGCAGTTGAAA 
                     551                                                600 
» Ov/Loa17DIII  (550)  ATACTACTCAAACTGATAATTTTAAAAGTGAAATAGTAAAAGACAACGAT 
    » Bm17DIII  (550)  ATACTACTCAAACTGATAATTTTAAAAGTGAAATAGTAAAAGACAACGAT 
      Contig 1  (550)  ATACTACTCAAACTGATAATTTTAAAAGTGAAATAGTAAAAGACAACGAT 
                     601                618 
» Ov/Loa17DIII  (600)  AAAATACTAATCAGTAAT 
    » Bm17DIII  (600)  AAAATACTAATCAGTAAT 
      Contig 1  (600)  AAAATACTAATCAGTAAT 
 
(b) Ov/Loa17DIII      MIKMNEKYVKELILLLLFAMIYTSLESNCEFWTEDDFHPFVPKSEEAREEY 
 Bm17DIII  MIKMNEKYVKELILLLLFAMIYTSLESNCEFWIEDDFHPFVPKSEEAREEY 
 
Ov/Loa17DIII      CGFFKEMNLSRNELMDTIRKWASKYGVLEQFDNYVDEELRYENMVYDIFKD 
Bm17DIII      CGFFKEMNLSRNELMDTIRKWASKYGVLEQFDNYVDEELRYENMVYDIFKD 
 
Ov/Loa17DIII    KVNSTCGSEKIKRTLFEITDLLTDRDTAQQTIQTKIDEIINNLNERERMEL 
Bm17DIII  KVNSTCGSEKIKRTLFEITDLLTDRDTAQQTIQTKIDEIINNLNERERMEL 
 
Ov/Loa17DIII     TQLWAILGEEAIIEAQDKFENGNSIWEAVENTTQTDNFKSEIVKDNDKILISN 
Bm17DIII  TQLWAILGEEAIIEAQDKFENGNSIWEAVENTTQTDNFKSEIVKDNDKILISN 
 
FIGURE 1  Data showed the DNA and amino acid sequence of Bm17DIII and its homologs in W. 
bancrofti, O.  volvulus and L. loa, (a) Bm17DIII and its DNA homologs with two bases difference i.e. at 98 & 
483; (b) BmR1 amino acid sequence was identical with W. bancrofti; whereas with O. volvulus and L. loa, a 
difference occurred  only at one amino acid coded by bases 97-99 i.e. a change from Ile (ATC) to Thr (ACC). 
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Antibody reactivity to the B. malayi BmR1 
antigen and its homolog  
For IgG4-ELISA, serum samples that 
demonstrated average optical density (OD) 
readings of ≥0.300 were considered to be  
positive (Rahmah et al., 2001a). The IgG4-
ELISA results showed that both recombinant 
antigens were 100% identical in reactivity with 
the various categories of sera (Table 1).  
  
TABLE 1  Comparison between IgG4 reactivities of BmR1 and Ov-BmR1/Ll-BmR1 using a panel of 262 
serum samples. BmR1 is the antigen expressed by Bm17DIII DNA sequence; while Ov-BmR1/Ll-BmR1 is the 
antigen expressed by the homolog of Bm17DIII DNA in O. volvulus and L.loa. 
 
Type of serum sample  No BmR1 (%) Ov-BmR1/ Ll-BmR1 (%) 
O. volvulus, mf positive 70   1   (1.43)     1   (1.43) 
L. loa, mf positive 14   6   (42.86)     6   (42.86) 
W. bancrofti, mf positive 33   8   (24.24)     8   (24.24) 
B. malayi, mf positive 28   28 (100)     28 (100) 
Trichuris trichiura 8   0     0 
Ascaris lumbricoides 8   0     0 
Mixed infection with T. trichuris,  
A. lumbricoides and hookworm 
8   0     0 
Entamoeba histolytica (invasive) 11   0     0 
Toxocara 14   0     0 
Gnathostoma spinegerum 1   0     0 
Strongyloides stercoralis 6   0     0 
Endemic normals 29   0     0 
Non-endemic normals 32   0     0 
TOTAL 262  
 
Reactivities of BmR1 and its O. volvulus/L. 
loa homolog with serum antibodies of the other 
three IgG subclasses (IgG1, IgG2 and IgG3) 
using samples from O. volvulus and L. loa 
infected individuals showed positive reactions 
with only IgG1. Most IgG1 positive samples 
showed OD >1.000. Similarly, the reactivities of 
anti-filarial IgG1, IgG2 and IgG3 antibody 
subclasses with BmR1 on serum samples from 
active and chronic cases W. bancrofti and B. 
malayi showed positive reactions only with 
IgG1. It is also noted that sera from non-
endemic normals and soil-transmitted infections 
also showed similar reactivities i.e. IgG1 
positive and IgG2 & IgG3 negative (Table 2).
 
TABLE 2  Results of ELISAs to detect IgG1, IgG2 and IgG3 anti-filarial antibodies in various kinds of 
serum samples using BmR1 and Ov-BmR1/Ll-BmR1. Both antigens (tested separately) demonstrated identical 
results with all serum samples. 
 
Number of positive results per number of samples tested Type of serum sample 
IgG1-ELISA IgG2-ELISA IgG3-ELISA 
O. volvulus mf+ 47/47 0/21 0/21 
L. loa mf+ 14/14 0/14 0/14 
W. bancrofti mf+ 6/6 0/6 0/6 
W. bancrofti chronic 6/6 0/6 0/6 
B. malayi  mf+ 10/10 0/10 0/10 
B. malayi chronic 14/14 0/14 0/14 
Non-endemic normals 10/10 0/10 0/10 
Soil-transmitted helminth infections 10/10 0/10 0/10 
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Discussion       
BmR1, a recombinant B. malayi antigen of 
~ 30 kDa expressed by Bm17DIII DNA 
coding sequence (cds), has been consistently 
shown to be a sensitive and specific antigen 
for immunodiagnosis of brugian filariasis in 
studies employing either 
immunochromatographic rapid test (Brugia 
Rapid) or ELISA (Rahmah et al., 2003a; 
Rahmah et al., 2003b). Multicenter 
evaluations performed on Brugia Rapid 
showed variable reactivity of BmR1 to sera of 
W. bancrofti infected patients. Reactivity to 
sera from Chennai, India was 54.5% (12/22); 
from Indonesia was 70% (14/20) and from 
Cook Island was 90% (9/10) (Rahmah et al., 
2003a). The wide variation in the reactivity of 
the assay in Bancroftian filariasis in the above 
three geographical areas prompted us to 
undertake the current investigation. The 
present study has shown that the homolog in 
W. bancrofti  is 100% similar to the cDNA of 
BmR1, irrespective of the source of the 
parasites- whether the mf were isolated from 
the individuals whose sera showed positive or 
negative reactivity with the BmR1 rapid test. 
Thus the observed differences in the reactivity 
of BmR1 antigen with W. bancrofti sera 
collected from different geographical regions 
does not appear to be due to genotypic 
variability between different isolates of mf. 
PCR experiments were repeatedly 
performed on the W. bancrofti genomic DNA 
samples to obtain an amplicon with a size 
greater than 618 bp since an intron is expected 
to be present in genomic material. However 
only one prominent band of 618 bp was 
obtained; and very occasionally a faint band 
of >1kb was observed which later was shown 
to be due to unspecific amplification. PCR on 
W. bancrofti genomic DNA to amplify the 
intron sequence (using primers based on 
Bm17DIII intron) produced a sequence that is 
~75% similar to intron of Bm17DIII. This is 
believed to be amplification on another part of 
W. bancrofti genome since PCR using a pair 
of internal primers that flank the possible 
intron site produced a PCR product of ~300 
bp, a size that is expected if there was no 
intron.  On the other hand amplification of B. 
malayi genomic material produced two kinds 
of amplicons i.e. 618 bp and 1010 bp. The 
latter comprised an intron (393bp) and two 
flanking exons (237bp and 381bp); the 
sequences were consistent with the B. malayi 
data at TIGR website.  Thus at USM, genomic 
DNA of Wb17DIII was found to be intronless; 
whereas genomic DNA of Bm17DIII was 
shown to have two variants i.e. one with and 
one without an intron. These results, though 
seemingly controversial, were a result of 
exhaustive effort with proper PCR controls. 
Reports from other laboratories will hopefully 
confirm these results. 
Anti-BmR1 IgG4 was detected in 84.6% 
(44/52) of L. loa sera but generally not 
detected in O. volvulus serum samples 
(Rahmah et al., 2003b; Fischer et al., in 
press). The BmR1 homologs of O. volvulus 
and L. loa were 100% identical to each other 
and 99.7% similar to the B. malayi and W. 
bancrofti homolog on the nucleotide level 
(Figure 1). The recombinant O. volvulus/ L. 
loa BmR1 homolog was found to display a 
100% similar reactivity compared to BmR1 
when tested with IgG4-ELISA on a panel of 
serum samples (Tables 1 & 2). Therefore, the 
difference of one amino acid between the O. 
volvulus/ L. loa and the B. malayi/ W. 
bancrofti BmR1 homologs did not alter their 
antigenicity. It is interesting to note that 
although IgG4 assays have been shown to be 
elevated in onchocerciasis in assays using 
other recombinant antigens (Lucius et al., 
1992), the IgG4 reactivity to BmR1 or Ov-
BmR1 in O. volvulus was generally negative. 
One possible explanation is that the Ov-BmR1 
is mostly expressed by adult worms, and the 
immune response to O. volvulus is 
predominantly due to mf (Kazura et al., 1993), 
this may explain the very poor IgG4 response 
to BmR1/ Ov-BmR1. It is possible that the 
uptake of antigen of lymphatic filariae by 
antigen presenting cells is significantly 
different compared to O. volvulus, where adult 
worms and mf reside either in subdermal 
nodules or in the skin. 
The BmR1 antigen and the O. volvulus/ L. 
loa homolog were also used to determine if 
IgG1, IgG2 or IgG3 antibodies in O. volvulus, 
L. loa, B. malayi and W. bancrofti sera 
samples were reactive with the recombinant 
proteins.  In all cases, only anti-filarial IgG1 
was reactive; while anti-filarial IgG2 and 
IgG3 assays were consistently negative. It is 
important to note that IgG1 antibodies to 
BmR1 and homologs are unspecific and 
without any diagnostic value. The BmR1 
antigen contains obviously widespread 
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epitopes which are recognized by IgG1 
antibodies. 
Based on the present report and previous 
studies with IgG4 reactivity,  BmR1 and its 
homologs in W. bancrofti, O. volvulus and L. 
loa induce IgG antibody responses restricted 
to IgG1 and IgG4 subclasses only. Unlike the 
anti-filarial IgG4 response in B. malayi 
infection, the IgG4 response to BmR1 in W. 
bancrofti and L. loa was not consistently 
detected in all infected individuals indicating 
that this recombinant antigen will not be of 
much utility for diagnosis of these two filarial 
infections. Although IgG1 response to BmR1 
was observed in all the filarial infections 
tested, it lacks specificity since it was also 
positive when tested with serum samples from 
normal individuals and with those harbouring 
other parasitic infections. 
The study demonstrates the presence of 
identical/almost identical homologs of the 
diagnostic BmR1 antigen in other filarial 
parasites, but they do not seem to induce 
consistent antibody responses in all infected 
subjects. Thus the immunogenicity of BmR1 
in brugian filariasis appears to be clearly 
different from that of bancroftian filariasis, 
onchocerciasis and loiasis. 
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